Long-Term Study That Measures the Safety and Efficacy of BMS-986165 in Participants With Psoriasis. - IM011-075
Updated: 15 October, 2020 | ClinicalTrials.gov
Print Friendly Summary
Inclusion Criteria: - Completion of the protocol-required treatment period in an applicable study of BMS-986165 in moderate-to-severe psoriasis - Women must not be pregnant, lactating, or breastfeeding Exclusion Criteria: - Any disease or medical condition that the investigator feels that would make the patient unsuitable for this study. - To be eligible for the study, a participant must not have active signs or symptoms of tuberculosis (TB) as judged by the investigator.